Anna Kilbey

Garscube Estate
Glasgow, SCT G611BD, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Integrin-dependent neutrophil slowing reduces lung perfusion and supports metastasis in a model of breast cancer.

Integrin-dependent neutrophil slowing reduces lung perfusion and supports metastasis in a model of breast cancer.

Journal: Cell reports

Published: August 02, 2024

Specialized Tfh cell subsets driving type-1 and type-2 humoral responses in lymphoid tissue.

Specialized Tfh cell subsets driving type-1 and type-2 humoral responses in lymphoid tissue.

Journal: Cell discovery

Published: December 17, 2023

β-Catenin Drives Butyrophilin-like Molecule Loss and γδ T-cell Exclusion in Colon Cancer.

β-Catenin Drives Butyrophilin-like Molecule Loss and γδ T-cell Exclusion in Colon Cancer.

Journal: Cancer immunology research

Published: August 09, 2022

NKG2D signaling regulates IL-17A-producing γδT cells in mice to promote cancer progression.

NKG2D signaling regulates IL-17A-producing γδT cells in mice to promote cancer progression.

Journal: Discovery immunology

Published: January 12, 2022

PD-1 and TIM-3 differentially regulate subsets of mouse IL-17A-producing γδ T cells.

PD-1 and TIM-3 differentially regulate subsets of mouse IL-17A-producing γδ T cells.

Journal: The Journal of experimental medicine

Published: July 03, 2021

Gut γδ T cells as guardians, disruptors, and instigators of cancer.

Gut γδ T cells as guardians, disruptors, and instigators of cancer.

Journal: Immunological reviews

Published: July 08, 2020

IL-27 maintains cytotoxic Ly6C+ γδ T cells that arise from immature precursors.

IL-27 maintains cytotoxic Ly6C+ γδ T cells that arise from immature precursors.

Journal: The EMBO journal

Published: July 06, 2020

The MSP-RON axis stimulates cancer cell growth in models of triple negative breast cancer.

The MSP-RON axis stimulates cancer cell growth in models of triple negative breast cancer.

Journal: Molecular oncology

Published: February 19, 2020

Disrupting MLV integrase:BET protein interaction biases integration into quiescent chromatin and delays but does not eliminate tumor activation in a MYC/Runx2 mouse model.

Disrupting MLV integrase:BET protein interaction biases integration into quiescent chromatin and delays but does not eliminate tumor activation in a MYC/Runx2 mouse model.

Journal: PLoS pathogens

Published: June 25, 2019

Collaboration of MYC and RUNX2 in lymphoma simulates T-cell receptor signaling and attenuates p53 pathway activity.

Collaboration of MYC and RUNX2 in lymphoma simulates T-cell receptor signaling and attenuates p53 pathway activity.

Journal: Journal of cellular biochemistry

Published: February 12, 2019

RUNX-mediated growth arrest and senescence are attenuated by diverse mechanisms in cells expressing RUNX1 fusion oncoproteins.

RUNX-mediated growth arrest and senescence are attenuated by diverse mechanisms in cells expressing RUNX1 fusion oncoproteins.

Journal: Journal of cellular biochemistry

Published: September 28, 2017

The RUNX Genes as Conditional Oncogenes: Insights from Retroviral Targeting and Mouse Models.

The RUNX Genes as Conditional Oncogenes: Insights from Retroviral Targeting and Mouse Models.

Journal: Advances in experimental medicine and biology

Published: March 17, 2017

Showing 1-12 of 19

Last Updated: 09/26/2026